- Home
- SNSE vs PMD Comparison
SNSE vs PMD Comparison
Compare SNSE & PMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- PMD
- Stock Information
- Founded
- SNSE 2005
- PMD 1986
- Country
- SNSE United States
- PMD United States
- Employees
- SNSE N/A
- PMD N/A
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- PMD Medical Specialities
- Sector
- SNSE Health Care
- PMD Health Care
- Exchange
- SNSE Nasdaq
- PMD Nasdaq
- Market Cap
- SNSE 12.3M
- PMD 13.7M
- IPO Year
- SNSE 2021
- PMD N/A
- Fundamental
- Price
- SNSE $0.45
- PMD $2.67
- Analyst Decision
- SNSE Strong Buy
- PMD
- Analyst Count
- SNSE 3
- PMD 0
- Target Price
- SNSE $4.33
- PMD N/A
- AVG Volume (30 Days)
- SNSE 330.7K
- PMD 58.8K
- Earning Date
- SNSE 11-14-2024
- PMD 11-12-2024
- Dividend Yield
- SNSE N/A
- PMD N/A
- EPS Growth
- SNSE N/A
- PMD N/A
- EPS
- SNSE N/A
- PMD N/A
- Revenue
- SNSE N/A
- PMD $20,258,000.00
- Revenue This Year
- SNSE N/A
- PMD N/A
- Revenue Next Year
- SNSE N/A
- PMD N/A
- P/E Ratio
- SNSE N/A
- PMD N/A
- Revenue Growth
- SNSE N/A
- PMD N/A
- 52 Week Low
- SNSE $0.38
- PMD $1.64
- 52 Week High
- SNSE $1.94
- PMD $3.95
- Technical
- Relative Strength Index (RSI)
- SNSE 47.08
- PMD 39.39
- Support Level
- SNSE $0.41
- PMD $1.11
- Resistance Level
- SNSE $0.50
- PMD $2.91
- Average True Range (ATR)
- SNSE 0.05
- PMD 0.37
- MACD
- SNSE -0.00
- PMD -0.08
- Stochastic Oscillator
- SNSE 34.09
- PMD 36.10
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.
About PMD Psychemedics Corporation
Psychemedics Corp is engaged in providing testing services for the detection of drugs of abuse through the analysis of hair samples. The company operates through a single segment of drug testing services which include training for the collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit testing of samples. The testing methods of the company utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. They provide testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples. Geographically it generates the majority of its revenue from the United States.